Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.
about
Astroglial expression of the P-glycoprotein is controlled by intracellular CNTF.The pharmacological impact of ATP-binding cassette drug transporters on vemurafenib-based therapyAntibody C219 recognizes an alpha-helical epitope on P-glycoproteinNuclear receptor response elements mediate induction of intestinal MDR1 by rifampinEffects of sertraline and fluoxetine on p-glycoprotein at barrier sites: in vivo and in vitro approachesDrug excretion mediated by a new prototype of polyspecific transporterP-glycoprotein (ABCB1) but not multidrug resistance-associated protein 1 (ABCC1) is induced by doxorubicin in primary cultures of rat astrocytesCharacterization of gastrointestinal absorption of digoxin involving influx and efflux transporter in rats: application of mdr1a knockout (-/-) rats into absorption study of multiple transporter substrateMajor vault protein LRP-related multidrug resistanceTargeting multidrug resistance in cancerA synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.Current approaches to enhance CNS delivery of drugs across the brain barriersP-glycoprotein acts as an immunomodulator during neuroinflammation.Comparison of three commercially available antibodies for flow cytometric monitoring of P-glycoprotein expression in tumor cells.Development of neuropeptide drugs that cross the blood-brain barrier.Multidrug resistance in oncology: diagnostic and therapeutic approaches.Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosisThe multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression.ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.Functional expression and localization of P-glycoprotein at the blood brain barrier.Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.Drug resistance in brain diseases and the role of drug efflux transporters.Expression and function of multidrug resistance transporters at the blood-brain barriers.Pluronics and MDR reversal: an update.Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycinBiodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.Functional evidence of multidrug resistance transporters (MDR) in rodent olfactory epitheliumMultidrug transporters in prokaryotic and eukaryotic cells: physiological functions and transport mechanisms.The blood-brain barrier in health and disease.Polymorphisms in the ABC drug transporter gene MDR1.The blood-brain barrier.Cloning and regulation of the rat mdr2 geneThe effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis studyAutoassembly protein arrays for analyzing antibody cross-reactivityFunctional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.Genetic aspects of multidrug resistance.Clinical relevance of P-glycoprotein in drug therapy.Reversal of MDR by verapamil analogues.Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings.
P2860
Q24798696-CB0FAA61-E95C-4EF4-B33C-2352BC5FD416Q27004672-57419B89-CA0D-4FE3-A76A-651EA9556BDBQ27620436-978148A3-05FB-4446-9D66-8CAFD5DAC182Q28211706-65C984C9-1B76-46F6-B9DB-3DD5359EB3DDQ28487360-B5DC7259-31B4-40A0-9B91-1A23013A6DD8Q28568689-0EEBA064-945B-4D91-BA1A-1E6B7A852D69Q28572696-93A51ED3-AD83-47EE-B645-DC942DE0C5CEQ28577650-B512A472-30F8-4130-8D06-81C08E6C2A16Q29031989-458DD3B9-0E28-4337-A198-856F530B1086Q29616803-06023FC9-5EB1-4B1A-BC0C-DE60CDA7AF92Q30375556-6608F0DB-ECB3-4EF3-AB4C-FA03E5DA6251Q30437835-441ED688-99AF-4C2B-9133-C509E580FFF3Q30973736-EF1F4B53-443E-44F3-A226-E7A1D67F1BFAQ33251656-9D5746B5-0F61-46B2-8C19-7D6A36120986Q33569277-4EB500CB-C2F3-4C00-B2D4-CA9ABED445F2Q33650232-4F770E21-F2FF-46DC-99BF-47F6CE3BBE5EQ33821114-D54A2671-BC4D-4C0E-BD93-0653C2256BBAQ33938687-A9ACCCF6-6F3F-4879-8B11-3D2CFB6A78CFQ33938893-8B339122-47DC-4DCE-9102-97EEA7E580F6Q33960099-9DC3206F-8033-49C3-8D75-4A4FB66F636CQ33985133-F1CE55DA-2463-4907-90EE-3174820EE054Q33988704-59E93B46-673E-49B2-A29C-65B5456215CBQ33998841-47B35750-EFF4-4CF2-B421-1EDFC07C9535Q34005678-946437CE-4164-4257-B89C-0C380CF3A295Q34049823-D30B75CF-1DB5-45FF-969D-5101D24A8A0EQ34102506-7F2339B0-EA07-427D-9E69-0611ADA7FC3EQ34260070-F6A44F5E-7688-4108-AC11-0E97CDAEFB00Q34276400-5ED8FA78-365B-43EC-BB65-2CD29C829304Q34320420-9B9F417C-8854-48CE-B9E6-411A0ABED3EDQ34576932-6539FC1A-6669-4947-9DF2-93FAF36B8D0DQ34931170-479A22A2-598C-4DAE-8D99-BB48DC9F3BFCQ34996267-85F3B692-CABF-494C-A98B-24FC82815E6DQ35044794-6F14B377-97EF-478B-975A-FB2902F1B86AQ35104617-3EFB35B1-2793-42F7-BAE9-7EC47DBD3ACBQ35113118-1C8E7AD3-D596-4806-A9A6-8BB4B58CA42AQ35171274-0F3E8EE7-4CF3-4F83-BB16-358BDEFEF22EQ35264223-9EBAEC7F-B5BB-42B0-91EC-3A311965487AQ35620664-5FD7F9F6-D216-4271-9FFE-ED87C4B99EBFQ35668684-D9C9B422-D11C-44EE-9E39-FFD587F702E3Q35708089-1106EC76-54C3-4A0D-B18E-EBE677F528A1
P2860
Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.
description
1989 nî lūn-bûn
@nan
1989 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Immunohistochemical localizati ...... ntibody with a muscle protein.
@ast
Immunohistochemical localizati ...... ntibody with a muscle protein.
@en
Immunohistochemical localizati ...... ntibody with a muscle protein.
@nl
type
label
Immunohistochemical localizati ...... ntibody with a muscle protein.
@ast
Immunohistochemical localizati ...... ntibody with a muscle protein.
@en
Immunohistochemical localizati ...... ntibody with a muscle protein.
@nl
prefLabel
Immunohistochemical localizati ...... ntibody with a muscle protein.
@ast
Immunohistochemical localizati ...... ntibody with a muscle protein.
@en
Immunohistochemical localizati ...... ntibody with a muscle protein.
@nl
P2093
P356
P1476
Immunohistochemical localizati ...... ntibody with a muscle protein.
@en
P2093
F Thiebaut
M C Willingham
M M Gottesman
P304
P356
10.1177/37.2.2463300
P577
1989-02-01T00:00:00Z